Pre-existing Hepatic Encephalopathy: Really a Contraindication to Elective TIPS?
Authors:
- 5 October 2023
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 47 (1) , 69-77
Abstract
Purpose To evaluate the impact of pre-transjugular intrahepatic portosystemic shunt (TIPS) hepatic encephalopathy (HE) on developing post-TIPS HE. Materials and Methods In this retrospective, single center observational study, all patients who underwent successful TIPS placement between January 2005 and May 2020 with data pertaining to HE in their chart were included. Patient demographics and procedural details were recorded. Clinical outcomes post-TIPS, were collected and compared across patients with and without pre-TIPS HE. Results Of 326 included patients, 159 (159/326, 48.8%) had a history of pre-TIPS HE. In total those without a history of HE were more likely to develop HE during follow up (136 (136/167, 81.4%) vs 107 (107/159, 67.3%), p = 0.001). When evaluating for predictors of developing HE within 3 months of TIPS placement, no significant variables were found on logistic regression, including prior history of HE (HR 1.16 (95% CI 0.73–1.84), p = 0.529). Univariate and multivariate regression analysis, however, showed that a history of HE was predictive of developing HE at any point in the follow-up period (p = 0.002 and p = 0.008, respectively). However, on Kaplan–Meier analysis no significant difference in the development of HE (p = 0.574) or hospital admission for HE (p = 0.554) post-TIPS was seen between patients with and without pre-TIPS HE. Additionally, there was no difference in 3-month survival (p = 0.412) or overall survival post-TIPS survival (p = 0.798). Conclusion Pre-TIPS HE did not predict the development of HE within 3 months of TIPS. Outcomes such as hospital admission and survivability were not different between patients with and without prior HE.Keywords
This publication has 25 references indexed in Scilit:
- Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt PlacementClinical Gastroenterology and Hepatology, 2017
- Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic ShuntsJournal of Vascular and Interventional Radiology, 2016
- Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal HypertensionJournal of Gastrointestinal and Liver Diseases, 2015
- Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical OutcomesDigestive Diseases and Sciences, 2014
- A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver TransplantationGastroenterology, 2011
- Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A systematic reviewJournal of Gastroenterology and Hepatology, 2011
- Early Use of TIPS in Patients with Cirrhosis and Variceal BleedingNew England Journal of Medicine, 2010
- Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experienceQJM: An International Journal of Medicine, 2008
- Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled studyJournal of Hepatology, 2005
- Effect of transjugular intrahepatic portosystemic shunt on quality of life.American Journal of Roentgenology, 1996